Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.

CONTEXT It has been hypothesized that increased plasma bile acids (BAs) contribute to metabolic improvements after Roux-en-Y gastric bypass (RYGB) surgery by the G protein-coupled receptor TGR5-mediated effects on glucagon-like peptide-1 secretion and thyroid hormones. OBJECTIVE The objective of this study was to evaluate the importance of bariatric surgery-induced alterations in BA physiology on factors that regulate glucose homeostasis (insulin secretion and sensitivity) and energy metabolism (resting energy expenditure and thyroid hormone axis). DESIGN, PARTICIPANTS, INTERVENTION, AND MAIN OUTCOME MEASURE: Eighteen extremely obese subjects were studied before and after 20% weight loss, induced by either laparoscopic adjustable gastric banding (LAGB) (n = 10) or RYGB surgery (n = 8). RESULTS Plasma BAs more than doubled after RYGB [fasting: 1.08 (0.26-1.42) to 2.28 (1.59-3.28) μmol/L, P = .03; postprandial: 2.46 ± 1.59 to 6.00 ± 2.75 μmol/L, P = .01] but were either lower or did not change after LAGB [fasting: 1.80 (1.49-2.19) to 0.92 (0.73-1.15) μmol/L, P = .02; postprandial: 3.71 ± 2.61 to 2.82 ± 1.75 μmol/L, P = .14]. Skeletal muscle expression of TGR5 targets, Kir6.2 and cyclooxygenase IV, increased after RYGB but not LAGB. Surgery-induced changes in BAs were associated with increased peak postprandial plasma glucagon-like peptide-1 (r(2) = 0.509, P = .001) and decreased serum TSH (r(2) = 0.562, P < .001) but did not correlate with the change in insulin response to a meal (r(2) = 0.013, P = .658), insulin sensitivity (assessed as insulin stimulated glucose disposal during a hyperinsulinemic-euglycemic clamp procedure) (r(2) = 0.001, P = .995), or resting energy expenditure (r(2) = 0.004, P = .807). CONCLUSIONS Compared with LAGB, RYGB increases circulating BAs and TGR5 signaling, but this increase in BAs is not a significant predictor of changes in glucose homeostasis or energy metabolism.

[1]  S. Klein,et al.  Gastric bypass and banding equally improve insulin sensitivity and β cell function. , 2012, The Journal of clinical investigation.

[2]  J. H. Bekker,et al.  The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. , 2012, Endocrinology.

[3]  F. Gonzalez,et al.  Bile Acids Acutely Stimulate Insulin Secretion of Mouse β-Cells via Farnesoid X Receptor Activation and KATP Channel Inhibition , 2012, Diabetes.

[4]  B. Laferrère.  Gut feelings about diabetes. , 2012, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[5]  J. Dixon,et al.  Surgical approaches to the treatment of obesity , 2011, Nature Reviews Gastroenterology &Hepatology.

[6]  Z. Meng,et al.  TGR5: A Novel Target for Weight Maintenance and Glucose Metabolism , 2011, Experimental diabetes research.

[7]  J. Stoker,et al.  Alterations of Hormonally Active Fibroblast Growth Factors after Roux-en-Y Gastric Bypass Surgery , 2011, Digestive Diseases.

[8]  S. Woods,et al.  Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[9]  H. Itoh,et al.  Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. , 2009, Metabolism: clinical and experimental.

[10]  J. Auwerx,et al.  TGR5-mediated bile acid sensing controls glucose homeostasis. , 2009, Cell metabolism.

[11]  J. Holst,et al.  Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism , 2009, Obesity.

[12]  A. Goldfine,et al.  Expansion and contraction: treating diabetes with bariatric surgery , 2009, Nature Medicine.

[13]  G. Dohm,et al.  Full and durable remission of type 2 diabetes? Through surgery? , 2009, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[14]  S. Ishizuka,et al.  Improved analysis of bile acids in tissues and intestinal contents of rats using LC/ESI-MSs⃞s⃞ The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of a figure. Published, JLR Papers in Press, September 4, 2008. , 2009, Journal of Lipid Research.

[15]  J. Auwerx,et al.  Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation , 2006, Nature.

[16]  K. Setchell,et al.  Serum Unconjugated Bile Acids as a Test for Intestinal Bacterial Overgrowth in Dogs , 2000, Digestive Diseases and Sciences.

[17]  Claudio Cobelli,et al.  Insulin release in impaired glucose tolerance: oral minimal model predicts normal sensitivity to glucose but defective response times. , 2002, Diabetes.

[18]  S. Kahn,et al.  Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. , 1994, The Journal of clinical investigation.